Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis.
Yuko KanbayashiYuichi IshizukaMayumi ShimizuShohei SawaKatsushige YabeMayako UchidaPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
High BMI, chemotherapy including a taxane within 1 month of evaluation of laxative effect, no use of naldemedine, and addition or switching due to insufficient prior laxatives were identified as risk factors for OIC in advanced cancer patients with cancer pain.